We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
- Authors
Giltnane, Jennifer M; Rydén, Lisa; Cregger, Melissa; Bendahl, Pär-Ola; Jirström, Karin; Rimm, David L
- Abstract
Although there is evidence for interaction between epidermal growth factor receptor (EGFR) and estrogen receptor (ER), it is still not clear how this affects response to endocrine therapies like tamoxifen. Here we assess the relationship between EGFR expression and tamoxifen response, with a new quantitative technology.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 21, p3007
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.08.9938